Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
16 February 2024Website:
http://chromocell.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 21 Jun 2024 21:27:59 GMTDividend
Analysts recommendations
Institutional Ownership
CHRO Latest News
OKLAHOMA CITY--(BUSINESS WIRE)--Paycom Software, Inc. (NYSE: PAYC) (“Paycom” or the “Company”), a leading provider of comprehensive, cloud-based human capital management software, announced that Randy Peck, a 20-year Paycom veteran, has been appointed to serve as Paycom's Chief Operating Officer, while Matt Paque and Jennifer Kraszewski have been promoted to Chief Legal Officer and Chief Human Resources Officer, respectively. “These promotions align with our ambition to continue to help Paycom.
Briones and Carey to join company's executive committee on Jan. 1, 2025 SAN FRANCISCO , May 22, 2024 /PRNewswire/ -- Prologis (NYSE: PLD) today announced Ed Nekritz and Colleen McKeown will retire as chief legal officer and chief human resources officer, effective January 1, 2025. Current Deputy General Counsel Deborah Briones and Senior Vice President of Human Resources Nathaalie Carey will succeed Nekritz and McKeown.
What type of business is Chromocell Therapeutics?
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
What sector is Chromocell Therapeutics in?
Chromocell Therapeutics is in the Healthcare sector
What industry is Chromocell Therapeutics in?
Chromocell Therapeutics is in the Biotechnology industry
What country is Chromocell Therapeutics from?
Chromocell Therapeutics is headquartered in United States
When did Chromocell Therapeutics go public?
Chromocell Therapeutics initial public offering (IPO) was on 16 February 2024
What is Chromocell Therapeutics website?
https://chromocell.com
Is Chromocell Therapeutics in the S&P 500?
No, Chromocell Therapeutics is not included in the S&P 500 index
Is Chromocell Therapeutics in the NASDAQ 100?
No, Chromocell Therapeutics is not included in the NASDAQ 100 index
Is Chromocell Therapeutics in the Dow Jones?
No, Chromocell Therapeutics is not included in the Dow Jones index
When does Chromocell Therapeutics report earnings?
Next earnings report date is not announced yet